Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary starch and other carbohydrates represent the primary macronutrient source of metabolic energy for the human body, ranging from simple monosaccharides like glucose to complex polysaccharides like starch and fiber (NIH, 2022). Upon ingestion, complex carbohydrates are hydrolyzed by digestive enzymes, including salivary and pancreatic alpha-amylase and membrane-bound intestinal alpha-glucosidases, into absorbable monosaccharides (StatPearls, 2023). While these molecules are not therapeutic targets in the traditional sense of being receptors or enzymes, they serve as the essential substrates for pharmacological interventions in metabolic diseases. Drugs such as alpha-glucosidase inhibitors are designed to interfere with the breakdown of these carbohydrates to delay glucose absorption and mitigate postprandial hyperglycemia (PubMed, 2021). Consequently, the management of carbohydrate metabolism is a central focus in the treatment of Type 2 diabetes, obesity, and metabolic syndrome (WHO, 2023).
Competitive inhibition of intestinal alpha-glucosidase enzymes and pancreatic alpha-amylase, which delays the hydrolysis of dietary starch and oligosaccharides into glucose, thereby slowing glucose absorption and reducing postprandial blood glucose excursions (StatPearls, 2023; PubChem, 2023).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary starch and other carbohydrates (CHO) (CHO).